SOD1, superoxide dismutase 1, 6647

N. diseases: 689; N. variants: 68
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.150 GeneticVariation phenotype BEFREE Of 636 people with ALS, 69% reported pain, of these most had mild pain. 31696295 2020
CUI: C0030193
Disease: Pain
Pain
0.150 Biomarker phenotype BEFREE The presence of pain at disease onset seems to relate to peculiar clinical features of ALS and may be pathophysiologically associated with neurodegeneration. 31634749 2019
CUI: C0030193
Disease: Pain
Pain
0.150 Biomarker phenotype BEFREE Oral pretreatment with the methanolic extract of <i>E. retusa</i> (200 mg/kg) exhibited a significant inhibition of pain induced either by acetic acid or by the heating plate and in a manner comparable to the standard drug paracetamol.<i>E. retusa</i> significantly reduced paw edema starting from the 3rd hour after carrageenan administration by increasing the activity of antioxidant enzymes (SOD, CAT, and GPx) in liver and paw tissues and decreasing the levels of MDA. 30073041 2018
CUI: C0030193
Disease: Pain
Pain
0.150 Biomarker phenotype BEFREE In a case-control study, we investigated the association between migraine and superoxide dismutase 1 (SOD1) and superoxide dismutase 2 (SOD2) genes in a cohort of 490 consecutive unrelated Caucasian migraineurs (migraine with aura [MwA], n=107; migraine without aura [MwoA], n=246; chronic migraine [CM], n=137) and 246 healthy controls recruited at our Headache and Pain Unit and stored in the Interinstitutional Multidisciplinary BioBank (BioBIM). 25295643 2015
CUI: C0030193
Disease: Pain
Pain
0.150 Biomarker phenotype BEFREE When fALS is compared clinically to sporadic ALS, 20% of cases manifest atypical features such as pain, paraesthesia or urgency micturition. 10448977 1999
CUI: C0030193
Disease: Pain
Pain
0.150 Biomarker phenotype HPO